AngioDynamics Says Rival Must Stay In $145M Damages Row
Medical device maker AngioDynamics Inc. pushed back Wednesday against a competitor's attempt to toss racketeering claims, arguing in Massachusetts federal court that the competitor is culpable in Biolitec AG's alleged scheme...To view the full article, register now.
Already a subscriber? Click here to view full article